Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suyu Shu

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Blood|February 8, 2007
Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor responseLi-Xin Wang, Suyu Shu, Mary L Disis, et al.
Head & Neck|January 8, 2010
Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybridsWalter T Lee, Chunrui Tan, Gary Koski, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Immunotherapeutic reactivity of dendritic cells loaded with a variety of antigen preparations]Keiji Shimizu, Hideyuki Kuriyama, Hidemasa Tamai, et al.
American Journal of Otolaryngology|November 6, 2007
RAD inhibition of sarcoma growth: implications for laryngeal transplantationPhilip Daniel Knott, Hidemasa Tamai, Marshall Strome, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapyKeiji Shimizu, Hideyuki Kuriyama, Jorgen Kjaergaard, et al.
Archives of Otolaryngology--Head & Neck Surgery|June 19, 2008
Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybridsWalter T Lee, Hidemasa Tamai, Peter Cohen, et al.
Cancer Treatment and Research|October 24, 2007
Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapyRongxiu Zheng, Jorgen Kjaergaard, Walter T Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
IL-12 is required for anti-OX40-mediated CD4 T cell survivalCarl E Ruby, Ryan Montler, Rongxui Zheng, et al.
Journal of Neurosurgery|August 27, 2005
Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccinesJorgen Kjaergaard, Li-Xin Wang, Hideyuki Kuriyama, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 12, 2005
Tumor-dendritic cell fusion as a basis for cancer immunotherapyWalter T Lee, Keiji Shimizu, Hide Kuriyama, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Blood|February 8, 2007
Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor responseLi-Xin Wang, Suyu Shu, Mary L Disis, et al.
Head & Neck|January 8, 2010
Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybridsWalter T Lee, Chunrui Tan, Gary Koski, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Immunotherapeutic reactivity of dendritic cells loaded with a variety of antigen preparations]Keiji Shimizu, Hideyuki Kuriyama, Hidemasa Tamai, et al.
American Journal of Otolaryngology|November 6, 2007
RAD inhibition of sarcoma growth: implications for laryngeal transplantationPhilip Daniel Knott, Hidemasa Tamai, Marshall Strome, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapyKeiji Shimizu, Hideyuki Kuriyama, Jorgen Kjaergaard, et al.
Archives of Otolaryngology--Head & Neck Surgery|June 19, 2008
Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybridsWalter T Lee, Hidemasa Tamai, Peter Cohen, et al.
Cancer Treatment and Research|October 24, 2007
Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapyRongxiu Zheng, Jorgen Kjaergaard, Walter T Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
IL-12 is required for anti-OX40-mediated CD4 T cell survivalCarl E Ruby, Ryan Montler, Rongxui Zheng, et al.
Journal of Neurosurgery|August 27, 2005
Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccinesJorgen Kjaergaard, Li-Xin Wang, Hideyuki Kuriyama, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 12, 2005
Tumor-dendritic cell fusion as a basis for cancer immunotherapyWalter T Lee, Keiji Shimizu, Hide Kuriyama, et al.
Pageof 4